PD Dr. Benno Weigmann

Medizinische Fakultät

Depletion of CD56+CD3+invariant natural killer T cells prevents allergic inflammation in humanized mice (2021) Ose R, Weigmann B, Saloga J, Bellinghausen I Conference contribution Targeting of the Tec Kinase ITK Drives Resolution of T Cell–Mediated Colitis and Emerges as Potential Therapeutic Option in Ulcerative Colitis (2021) Lechner-Grimm K, Mott S, Al-Saifi R, Knipfer L, Wirtz S, Atreya R, Vieth M, et al. Journal article Depletion of CD56+CD3+ invariant natural killer T cells prevents allergen-induced inflammation in humanized mice (2021) Ose R, Weigmann B, Schuppan D, Waisman A, Saloga J, Bellinghausen I Journal article A group of cationic amphiphilic drugs activates MRGPRX2 and induces scratching behavior in mice (2021) Wolf K, Kühn H, Boehm F, Gebhardt L, Glaudo M, Agelopoulos K, Ständer S, et al. Journal article Analysis of in vitro and in vivo cross-tolerance induction by human IL-10 modulated dendritic cells from patients with birch-pollen related hazelnut allergies (2020) Rostan P, Graulich E, Weigmann B, Wangorsch A, Ose R, Bellinghausen , Scheurer S, et al. Conference contribution Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer (2020) Salazar Y, Zheng X, Brunn D, Raifer H, Picard F, Zhang Y, Winter H, et al. Journal article Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis (2020) Lechner KS, Neurath M, Weigmann B Journal article, Review article miRNA142-3p targets Tet2 and impairs Treg differentiation and stability in models of type 1 diabetes (2019) Scherm MG, Serr I, Zahm AM, Schug J, Bellusci S, Manfredini R, Salb VK, et al. Journal article Tumor immunoevasion by high glycolytic tumors through an acidosis-dependent induction of noninflammatory tumor-associated macrophages (2019) Bohn T, Rapp S, Pektor S, Gerlach K, Weigmann B, Lueckel C, Truong N, et al. Conference contribution Diminished allergen-induced intestinal and airway inflammation in humanized mice by depletion of natural killer cells prior to PBMC engraftment (2019) Ose R, Weigmann B, Maxeiner J, Schuster P, Saloga J, Bellinghausen I Conference contribution